Related Experiment Video

Updated: Jul 25, 2026

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
10:50

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Published on: June 29, 2013

The use of specific thromboxane inhibitors to preserve the dermal microcirculation after burning

E J DelBeccaro, M C Robson, J P Heggers

    Surgery
    |February 1, 1980
    PubMed

    Insights

    Selective thromboxane inhibitors effectively prevented progressive dermal ischemia in burn injuries. These agents improved blood flow and preserved skin structures, offering a targeted therapeutic approach.

    Area of Science:

    • Pharmacology
    • Dermatology
    • Wound Healing

    Background:

    • Progressive dermal ischemia is a significant complication following burns.
    • Thromboxane is implicated in the pathophysiology of burn-induced ischemia.
    • Current treatments for burn ischemia have limitations.

    Purpose of the Study:

    • To evaluate selective thromboxane inhibitors for preventing progressive dermal ischemia after burns.
    • To assess the impact of thromboxane inhibition on dermal perfusion and tissue survival.

    Main Methods:

    • Standardized partial-thickness burns were induced in guinea pigs.
    • Animals were treated with Imidazole, dipyridamole, or methimazole, or served as controls.
    • Dermal perfusion was assessed using India ink, and histology evaluated tissue preservation.

    Main Results:

    • Untreated controls exhibited complete dermal ischemia within 24 hours.
    • Imidazole, dipyridamole, and methimazole significantly improved dermal perfusion.
    • Treated animals showed enhanced preservation of dermal appendages, including an eight-fold increase in hair follicles.

    Conclusions:

    • Thromboxane plays a critical role in progressive dermal ischemia post-burn.
    • Selective thromboxane inhibition is a promising strategy for burn wound management.
    • This approach offers advantages over complete arachidonic acid metabolism suppression.

    More Related Videos

    Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans08:21

    Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

    Published on: July 21, 2023

    A Swine Burn Model for Investigating the Healing Process in Multiple Depth Burn Wounds02:49

    A Swine Burn Model for Investigating the Healing Process in Multiple Depth Burn Wounds

    Published on: February 23, 2024

    Related Concept Videos

    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

    Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

    Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
    Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...